izpis_h1_title_alt

Ovrednotenje vpliva storitve pregled uporabe zdravil na pacientovo razumevanje zdravljenja z zdravili
ID Brčan, Tina (Avtor), ID Kos, Mitja (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Nabergoj Makovec, Urška (Komentor)

.pdfPDF - Predstavitvena datoteka, prenos (1,91 MB)
MD5: 5B20E769B5C1E6B7EA4BE67A85231557

Izvleček
Uvod. Na področju zdravljenja z zdravili se soočamo z mnogimi izzivi, enega izmed njih predstavlja slabo sodelovanje pacientov pri zdravljenju z zdravili, do katerega lahko pride tudi zaradi nepoznavanja in nerazumevanja zdravljenja z zdravili. Storitev pregled uporabe zdravil je kognitivna storitev farmacevta, ki se osredotoča na pacientovo uporabo zdravil in razumevanje zdravljenja z njimi. Med cilji storitve je tudi izboljšanje pacientove seznanjenosti z zdravili in posledično preko opolnomočenja pacienta prispevati k boljšim zdravstvenim izidom. Namen. Z magistrsko nalogo smo želeli ovrednotiti pacientovo razumevanje zdravil za zdravljenje kroničnih bolezni. Ugotoviti smo želeli tudi, ali storitev pregled uporabe zdravil vpliva na izboljšanje poznavanja pacientovih zdravil. Metode. Podatke o razumevanju pacientov smo pridobili v okviru randomizirane kontrolirane klinične raziskave, kjer so pacienti razporejeni v testno skupino na srečanju 1 prejeli PUZ, pacienti v kontrolni skupini pa standard oskrbe. Po 12 tednih so pacienti obeh skupin prišli na ponovno ovrednotenje preiskovanih parametrov. Razumevanje smo ovrednotili za vsa pacientova zdravila, namenjena kronični uporabi, preko treh vprašanj o namenu uporabe zdravil, režimu odmerjanja ter o poznavanju posebnih opozoril. Pravilnost odgovora smo ovrednotili kot pravilen, napačen in ne ve. Enota analize je bila pacient-zdravilo, preko katere smo preverili raven razumevanja in spremembe med srečanjema na celotnem vzorcu ter primerjalno med testno in kontrolno skupino. Dodatno smo preverili še raven razumevanja glede na vrsto zdravila po posameznih ATC skupinah. Rezultati. V analizi smo uporabili odgovore 153 pacientov iz srečanja 1 ter 140 pacientov iz srečanja 2. Velikost vzorca glede na enoto analize je znašala 1116 pacient-zdravil. Pacienti dobro poznajo namen uporabe svojih zdravil (90,2 % pravilnih odgovorov na obeh srečanjih) kot tudi celokupni dnevni odmerek (89,4 % in 92,6 % pravilnih odgovorov na srečanju 1 in 2). Še višje odstotke pravilnih odgovorov so dosegli pacienti pri novo uvedenih zdravilih (94 % za namen in 88 % za celokupni dnevni odmerek). Analiza razumevanja glede na vrsto zdravil je pokazala, da pacienti slabše poznajo namen uporabe pri ATC skupini zdravil za bolezni srca in ožilja (C) ter za bolezni sečil in spolovil (G). Pri režimu odmerjanja so najtežavnejša zdravila za bolezni čutil (S), dihal (R) ter prebavil in presnove (A), pri celokupnem dnevnem odmerku pa poleg omenjenih še skupina N (zdravila z delovanjem na živčevje). Pritrdilen odgovor o poznavanju posebnih opozoril na srečanju 1 smo dobili pri 15 % pacient-zdravilih, na srečanju 2 pa pri 11,2 % pacient-zdravilih. Zaključek. Poznavanje zdravil med pacienti v naši raziskavi je na visoki ravni. Deset odstotkov pacientov izkazuje težave z razumevanjem namena in odmerjanja zdravil (merjenega s celokupnim dnevnim odmerkom), vendar pri njih PUZ stanja ni uspel izboljšati.

Jezik:Slovenski jezik
Ključne besede:razumevanje zdravljenja z zdravili, namen uporabe, celokupni dnevni odmerek, pregled uporabe zdravil, randomizirana kontrolirana klinična raziskava.
Vrsta gradiva:Magistrsko delo/naloga
Organizacija:FFA - Fakulteta za farmacijo
Leto izida:2019
PID:20.500.12556/RUL-112653 Povezava se odpre v novem oknu
Datum objave v RUL:30.10.2019
Število ogledov:1356
Število prenosov:263
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Evaluation of the impact of medication use review service on patient's understanding of pharmacotherapy
Izvleček:
Introduction. There are many challenges in the field of medicine treatment, one of this is poor patients' adherence to medicine treatment, which may also be due to lack of knowledge and lack of understanding of medicine therapy. The Medication Use Review service is a pharmacist's cognitive service that focuses on the patient's use of the medicines and understanding the treatment with them. One of the goals of the service is to improve patient's awareness of medicines and consequently contribute to better health outcomes through empowering the patient. Aim. We aimed to evaluate patient's understanding of medicines for the treatment of chronic diseases and to determine whether the Medication Use Review service has an impact on improving the patient's knowledge of medicines. Methods. Data about patients' understanding were obtained in a randomized controlled clinical trial, where patients randomized to the test group received MUR at meeting 1, while patients in control group received standard care. After 12 weeks, patients from both group came to re-evaluate the investigated parameters. We evaluated understanding of all patient's medication for chronic use through three questions about the purpose of medicine, dosing regimen and knowledge of special warnings. We evaluated the correctness of the answer as correct, incorrect and doesn't know. The unit of analysis was patient-medicine, which was used to evaluate the level of understanding and change between meetings on the entire sample and comparatively between test and control group. We additionally checked the level of understanding medicine type regarding individual ATC groups. Results. In the analysis we used the answers of 153 patients from meeting 1 and 140 patients from meeting 2. The sample size per unit of analysis was 1116 patient-medicines. Patients have good knowledge of the purpose of using their medicines (90.2% of correct answers in both meetings) as well as the total daily dose (89.4% and 92.6% of correct answers in meetings 1 and 2). Even higher percentages of correct answers were achieved by patients with newly introduced drugs (94% for the purpose and 88% for the total daily dose). The analysis of the understanding by type of medication revealed, that patients have less knowledge about the purpose of use in the ATC groups for cardiovascular system treatment (C) and genito-urinary system (G). In the dosage regimen, the most problematic medicines are those for the sensory organ (S), respiratory system (R), and alimentary tract and metabolism treatment (A), for the total daily dose the most problematic are the group N (medicines for nervous system treatment) and others, which are mentioned earlier. We obtained the affirmative answer on knowledge of special warnings on meeting 1 at 15% of patient-medicines and 11.2% of patient-medicines at meeting 2. Conclusion. Understanding the use of medicines is high among patients in our research. Ten percent of patients reported difficulty with understanding the purpose and dosage of the medicines (measured by the total daily dose), however MUR was unsuccesful in improving their status.

Ključne besede:understanding treatment with medicines, purpose of use, total daily dose, medication use review, randomised controlled clinical research.

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj